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Background: Bacterial vaginosis (BV) is the most common cause of vaginal discharge in
women of reproductive age. The purpose of this study was to determine the frequency of
BV in Bulgarian pregnant and nonpregnant women from several age ranges and to compare
three different laboratory methods for Gardnerella vaginalis detection in patents suffering
from BV.
Methods: Between September 2011 and June 2012, 809women of 16–40 years of age separated
in twomajor groups: nonpregnant – 469 (355 with and 114 without symptoms) and pregnant
– 340 (213 and 127 respectively) were enrolled for the study. The women underwent three
different laboratory tests simultaneously: scoring of Gram staining of vaginal smear, culture,
and polymerase chain reaction (PCR) assay for G. vaginalis.
Results: The microscopic method detected high frequency of BV in symptomatic (57%)
whereas only a minority of asymptomatic subjects (14%) were detected. G. vaginalis-
associated BV was diagnosed in approximately equal proportions when evaluated with PCR
andmicroscopicmethod for bothpregnant andnonpregnantwomen. The comparative anal-
ysis of microscopic evaluation, culture and PCR assays demonstrated greater concurrence
(about 90%) between Gram staining and PCR detection for BV, than both methods com-
pared to culture. The combination of microscopy and PCR turned out to be very reliable and
repeatable for detecting G. vaginalis-associated BV.
Conclusions: This is the ﬁrst comparative investigation on the epidemiology of G. vaginalis-associated BV in Bulgaria. The established highest frequency in the young Bulgarianwomen
(21–30 years) is alarming and should be considered in prophylaxis and reproductive pro-
grammes.
urally occurring microﬂora. Any change in the resident ﬂora
© 2013 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDntroductionacterial vaginosis (BV) is the most common cause of
npleasant vaginal odor and discharge in women of
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including reduction of lactobacilli allows for different anaer-
obic bacteria to gain a foothold and multiply.3–7 Nevertheless
the process is multifactorial and the initial mechanism of
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replacement of normal lactobacillary ﬂora by opportunistic
pathogens in vaginal ecosystem and the role of intrinsic
host factors still remains unclear, requiring more research to
be conducted.5–8 The essential participants in pathological
polymicrobial associations, which could be used as markers
for BV, are Gardnerella vaginalis (that grows under appropri-
ate microaerophilic conditions) and anaerobic Atopobium
vaginae.3–8 Other microorganisms involved in BV microbiota
are very diverse and include anaerobes, such as Peptostrep-
tococcus spp., Mobiluncus spp., Prevotella spp., Bacteroides spp.,
Fusobacterium spp., and facultative anaerobes.6–11 It is not
clear yet if the BV is a sexually transmitted disease, but it
is more common in promiscuous women with hazardous
sexual behavior (with multiple and/or new sexual partners; or
with female partners, sex during menses).12–18 BV can be an
independent risk factor for acquisition of any other sexually
transmitted infection.1,15,17 It has also been shown to be a
cause for serious health problems as preterm birth, postpar-
tum fever, development of endometritis, post-hysterectomy
or postabortal sepsis, and pelvic inﬂammatory disease.19–21
The purpose of this study was to determine the frequency
of BV and G. vaginalis-associated BV in Bulgarian pregnant
and nonpregnant women from different age ranges and to
compare three distinct laboratory methods for G. vaginalis
detections in patients suffering from BV.
Methods
Patients and clinical samples
From September 2011 till June 2012 we obtained vaginal
samples from 568 women with evident clinical symptoms
of vaginal discharge and from 241 asymptomatic women of
reproductive age (range 16–40 years). No women had received
antimicrobial therapy for at least a week before examination.
According to the pregnancy status, subjects were divided into
two groups: nonpregnant – 469 women (355 with and 114
without symptoms), and pregnant – 340 women (213 and 127
respectively).
Gram staining
From the vaginal samples we prepared smears and classiﬁed
them into three major groups, using the Nugent scale (range
from 0 to 10)22 and the modiﬁed scoring method with ﬁve
grades of ﬂora described by Ison and Hay.23 The ﬁrst group
was comprised of subjects with normal vaginal ﬂora – NVF
(Nugent score 0–3; Ison/Hay score 0-I). The second group –with
transition between normal ﬂora and BV – TVF (Nugent score
4–6; Ison/Hay score II), the third group was with BV (Nugent
score 7–10; Ison/Hay score III). The latter group was subdi-
vided in two subgroups IIIA (true BV) and IIIB – BV, more rare
type that was just outside the used scoring criteria and there
were no positive data from other investigations (complicated
with other vaginal pathogen – single areas with polymor-
phonuclear leukocytes and Trichomonas vaginalis or Candida
spp.).
The use of Amsel’s criteria was based on some clinical
symptoms that could not be standardized, so we did not13;17(3):313–318
include them in the assessment, but we evaluated the most
important and signiﬁcant laboratory indication for BV which
was conﬁrmation thatmore than 20% from the total cell popu-
lation were clue cells in the oil immersion ﬁelds of the vaginal
smear that coincides with Nugent score 7–10 and Ison/Hay
score III.22–24
Culture
The samples were cultivated in aerobic conditions on non-
selective sheep blood agar and MacConkey agar (for residentl
microﬂora) and Sabouraud’s agar for Candida spp.
For detection of G. vaginalis we used Columbia blood agar
base with G. vaginalis Selective Supplement SR0119E, Oxoid
(with gentamicin and nallidix acid) in microaerophilic atmo-
sphere (5–10% CO2) at 36 ◦C for 48–72h. The Gram-negative or
Gram-variable short rods, transparent colonies, -hemolytic
onhumanbloodagar, catalase-negative, Glucose, Prolin,ONPG
positive, were presumptively identiﬁed as G. vaginalis using
Remel RapID NH.
The presence of T. vaginalis in vaginal sampleswas detected
by its morphological characteristic of microscopic strain.
DNA isolation
Total DNA from vaginal samples was isolated using the DNA-
sorb-AM nucleic acid extraction kit (AmpliSens) according to
the manufacturer’s guidelines.
Polymerase chain reaction (PCR) assay
Aspecies-speciﬁc PCRassay for thedetectionofG. vaginalis tar-
geting the 16S rRNAgenewasperformed. Theoligonucleotides
used as primers for ampliﬁcation were GV1-F (5′-TTACTGG-
TGTATCACTGTAAGG-3′) and GV3-R (5′-CCGTCACAGGCTGA-
ACAGT-3′) synthesized by Alpha DNA.25 They were veriﬁed for
speciﬁcity using the BLAST program.
PCRwas carried out in a total volume of 25.0 (L and the ﬁnal
concentration of themix for each sample contained: 0.25 (M of
each primer, 0.2mM dNTPs, 1х Reaction Buffer, 2.0mM MgCl2
and 1.5U Taq DNA polymerase (Prime TaqTM DNA Polymerase,
GENET BIO). The DNA was ampliﬁed using the following pro-
tocol: an initial denaturation (94 ◦C for 5min), followed by 30
cycles of denaturation (94 ◦C for 45 s), annealing (60 ◦C for 45 s)
and extension (72◦ C for 45 s), with a single ﬁnal extension of
7min at 72 ◦C. PCR products were separated in 1% agarose gel
for 45min at 140V, stained with ethidium bromide (0.5g/mL)
and detected by UV transillumination (wavelength 312nm).
Ampliﬁed genes were identiﬁed on the basis of their expected
fragment size (331bp).The data were analysed using Chi-square and Fisher’s exact
tests. The results are expressed with calculated standard
deviations (SD). We considered p values of ≤0.05 to indicate
statistical signiﬁcance.
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Table 1 – Concordance between the groups of women on the basis of three different laboratory methods.
Groups of women Methods for detection of G. vaginalis
Gram staining (by common
criteria of Nugent and
Ison/Hay and presence of
Clue cells >20% in ﬁeld)
No (%±SD)
Culture method for
detection of G. vaginalis
No (%±SD)
PCR method for detection
of G. vaginalis
No (%±SD)
With TVF With BV With TVF With BV With TVF With BV
Pregnant women
symptomatic
(n=213)
26 (12.21± 4.40) 126 (59.15± 6.60) 8 (3.76± 2.55) 56 (26.29± 5.91) 12 (5.63± 3.10) 124 (58.22± 6.62)
Pregnant women
asymptomatic
(n=127)
22 (17.32± 6.58) 18 (14.17± 6.07) 4 (3.15± 3.03) 11 (8.66± 4.89) 7 (5.51± 3.97) 16 (12.60± 5.77)
Nonpregnant
women
symptomatic
(n=355)
37 (10.42± 3.18) 199 (56.06± 5.16) 10 (2.82± 1.72) 112 (31.55± 4.83) 20 (5.63± 2.40) 195 (54.93± 5.18)
Nonpregnant
women
asymptomatic
(n=114)
19 (16.67± 6.91) 15 (13.16± 6.27) 4 (3.50± 3.40) 8 (7.02± 4.74) 6 (5.26± 4.14) 13 (11.40± 5.89)
All symptomatic
(n=568)
63 (11.09± 2.58) 325 (57.22± 4.07) 18 (3.17± 1.44) 168 (29.58± 3.75) 32 (5.63± 1.90) 319 (56.16± 4.08)
All asymptomatic
(n=241)
41 (17.01± 4.74) 33 (13.69± 4.34) 8 (3.32± 2.26) 19 (7.88± 3.40) 13 (5.39± 2.85) 29 (12.03± 4.11)
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esults and discussion
he data from the three procedures for BV and G. vaginalis
etection in different groups of women are presented in
able 1.
Our results from PCR assay are shown in Fig. 1.
The group distributions of the additive isolates from aero-
ic cultures are summarized in Table 2.
The correlations between some demographic parameters
i.e. age range) with presence ofG. vaginalis and BV are demon-
trated in Table 3.
G. vaginalis was most frequently present in samples
btained from Bulgarian women in age range 21–30 years.
For achieving the goal of this investigation, the Nugent’s
core22 was taken as gold standard and the results from the
ther methods were compared with this score. As already
ig. 1 – Species-speciﬁc PCR assay for the detection of G.
aginalis in vaginal samples (agarose gel-electroforesis of
CR products of the 16S rRNA gene). The product size is
31bp. From right to left: 100bp Ladder and 9 (+) positive
amples.published by other authors it was preferable to recommend
the use of Ison/Hay method,23 because in that way we could
evaluate vaginal smears in ﬁve more clearly distinguished
grades with better segregation of the vaginal microﬂora.9,26,27
Using Gram straining in this studywe detected high frequency
of BV in symptomatic subjects (57.22%), in contrast to asymp-
tomatic Bulgarian women (13.69%). We could also prove TVF
in 11.09% of symptomatic and in 17.01% of asymptomatic
subjects. Our results for TVF frequency are in unison with
previously reported data in other studies from France and
Australia.3,28 BV frequency in the present study with Bulgar-
ian women is similar to that found in Nigerian women, with a
slightly higher rate in our population.29 We have shown that
BV occurs in approximately equal proportions when eval-
uated with the microscopic method for both pregnant and
nonpregnant symptomatic and pregnant and nonpregnant
asymptomatic women. These results are in contrast to data
obtained by other authors, claiming that BV is more frequent
during the pregnancy, which we could explain by separating
our groups according to the symptoms, and not only by
pregnancy status. So far all studies revealed different and
sometimes conﬂicting results for BV epidemiology.1,2,9,10,27,29
We found with PCR that pregnant symptomatic patients
with BV and TVF were positive for G. vaginalis in 58.22% (very
similar to the 59.15% with Gram straining) and 5.63%, respec-
tively. The group of nonpregnant symptomatic women had
positive samples in 54.93% (56.06% using Gram straining) for
BV and 5.63% for TVF (Table 1).
Using a selective agar media the isolation rate of G. vagi-
nalis as marker for BV was signiﬁcantly lower – only in half of
the cases (Table 1). The comparative analysis of microscopic
316 braz j infect d i s . 2013;17(3):313–318
Table 2 – Isolate distribution among 104 women with diagnosis TVF and 358 women with BV according to Gram
staining.a
Microorganism Group II (TVF=104)
No (%)
Group IIIA (BV=358)
No (%)
Group IIIB (BV=358)
No (%)
Lactobacillus spp. 59 (56.74) 6 (1.68) 0
Staphylococcus aureus 0 11(3.07) 0
Enterococcus faecalis 3 (2.88) 17 (4.75) 9 (2.51)
Corynebacterium spp. 2 (1.92) 8 (2.23) 0
Escherichia coli 0 9 (2.51) 11(3.07)
Klebsiella spp. 0 7 (1.96) 4 (1.12)
Candida albicans 0 0 19 (5.31)
Candida glabrata 0 0 2 (0.56)
Candida krusei 0 0 4(1.12)
Candida tropicalis 0 0 3 (0.84)
Candida parapsilosis 0 0 2 (0.56)
Trichomonas vaginalis 0 0 49 (13.69)
a More than one isolate were detected in some samples.
Table 3 – Association of age range with BV according Gram staining.
Age range TVF=104
No (%±SD)
BV=358
No (%±SD)
16–20 28 (26.92± 8.61) 29 (8.10± 2.83)
21–25 19 (18.27± 7.50) 101 (28.21± 4.66)
26–30 21 (20.19± 7.79) 96 (26.92± 4.59)
31–35 20 (19.23± 7.65) 70 (19.23± 4.08)
36–40 18 (17.30± 7.34) 62 (17.51± 3.92)SD, standard deviation.
evaluation, culture and PCR assays demonstrated greater
concurrence (about 90%) between Gram staining and PCR
detection for BV, than both methods compared to culture
(Table 1). We found that 89% of BV and only 28% of TVF (where
clue cells were signiﬁcantly less than in BV) groups, according
to themicroscopic criteria, had positive PCR forG. vaginalis.All
PCR positive results forG. vaginalis had either BV or T. vaginalis.
The combination of Gram staining and PCR methods showed
very reliable and repeatable detection of BV, unlike culture,
where only about 50% of PCR positive samples had evident
growth on the selective agarmedia forG. vaginalis. PCR assay is
themost sensitivemethod for routing outG. vaginalis (p<0.05),
but combination of this test with Gram staining for full char-
acterization in the patient is needed. Gram staining is an easy,
fast and affordable method that could be used, especially in
low-income countries, instead of PCR, when for various rea-
sons molecular detection is not possible, since the results of
both techniques are very similar. Thehigh frequency ofG. vagi-
nalis detected by PCR was evident such that this pathogen had
a very important role in the aetiology of BV. The results of
this study supported the data from previously reported stud-
ies where 68–100% of the patients with BV were positive to G.
vaginalis.3,9,27
The microbial growth on a non-selective agar media gave
useful information for the presence or absence of additional
microﬂora in the pathological process and this procedure
should not be skipped, despite having low sensitivity for
diagnosing BV. By using this routine method we identiﬁed
that the most frequently isolated microorganisms coloniz-
ing the vaginal mucosa and associated with BV, other thanG. vaginalis, were Enterococcus faecalis, Staphylococcus aureus,
Corynebacterium spp., Escherichia coli andKlebsiella spp. (Table 2).
Their role was unclear, as they might be of transient pres-
ence or as they were detected with moderate frequency they
could relate to BV aetiology or just be a co-infection. We
could not ﬁnd any conﬁrmed results or evidence for their
role published elsewhere. Our data showing Lactobacillus spp.
as the predominant bacterial genus present in the vaginal
microbiota in the smears and isolates of I-st (NVF) and II-nd
group (TVF) according to microscopic evaluation and culture
is in line with previously published studies.7,8,24 The Gram-
positives were the predominant bacterial microﬂora in the
IIIA group in contrast to the group IIIB where prevailed some
Gram-negatives species (Table 2). Some of the isolates such as
Candida spp. were detected only among patients of group IIIB,
more often inpregnantwomenandas initial colonizationafter
BV (Table 2). In 13.69% of Bulgarian women T. vaginalis was
detected in association with BV (IIIB group). Similar to other
reports, trichomoniasis was a frequent infection, and has to
be timely diagnosed for its importance as a causative agent
of sexually transmitted diseases with difﬁcult and sometimes
poor therapeutic response.18,29
BV in Bulgarian pregnant and nonpregnant women was
predominantly diagnosed in the age range of 21–25 years
(28.21% of all positive samples) and similarly but to a slight
lesser extent in the age group of 26–30 years (26.82%). Women
in the age ranges 31–35 and 36–40 years had similar detec-
tion rates in both groups, which were signiﬁcantly lower as
compared with the previous two age groups. In the youngest
group (age below 20 years) BV was detected in only about 8%,
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hereas TVF was found in 26.92% of women in this age group.
ur ﬁnding did not differ signiﬁcantly from those published
or Indian women, where BV prevalence in age group of 26–30
ears was 23% and in 7% among the youngest group (15–20
ears).30 The only difference between the Indian results and
urs was in the group of 21–25 years, where BV was more
requent among Bulgarian women.
onclusion
o our knowledge, this is the ﬁrst comparative study utilizing
hree different laboratory methods that focuses on the epi-
emiology of G. vaginalis-associated BV in Bulgaria. Although
CR is the most sensitive method for the detection of G. vagi-
alis, but for the full characterization of the smears the joint
pplication of PCR and Gram staining is the best choice. An
mportant note is that Gram staining results are compatible
ith PCR results, since this method is fast, easy and inexpen-
ive, so that it could be used in developing countries, where
nd when molecular techniques are not available.
The high frequency in Bulgarian young women found in
his study is alarming, since BV increases woman’s suscepti-
ility to HIV, HPV and other important sexually transmitted
iseases. Therefore BV has to be correctly and timely diag-
osed in order to be adequately treated.
Further investigations regarding other pathogens involved
n BV such as A. vaginae and Mobiluncus spp. are warranted.
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